Publications by authors named "Eva Vrscaj"
Article Synopsis
- * A study involving 99 SMA type I-III patients examined the perceptions of treatment benefits among different outcome groups, consisting of those with significant, non-significant, or no improvement after 15 months of treatment.
- * The findings indicate that there is little difference in how patients and caregivers perceive the benefits of treatment among the different groups, suggesting that standard functional scales may not fully capture their real-life experiences with the treatment.
Background And Objectives: In children requiring electroencephalography (EEG), sleep recording can provide crucial information. As EEG recordings during spontaneous sleep are not always possible, pharmacological sleep-inducing agents are sometimes required. The aim of the study was to evaluate safety and efficacy of melatonin (Mel) and dexmedetomidine (Dex; intranasal and sublingual application) for sleep induction prior to EEG.
View Article and Find Full Text PDFSpinal muscular atrophy (SMA) is a rare and devastating disease. New disease-modifying treatments have recently been approved and early treatment has been related to a better outcome. In this context, several newborn screening (NBS) programs have been implemented.
View Article and Find Full Text PDFAim: The aim of this study was to evaluate the perceived health of children with epilepsy as experienced by the respondents to a questionnaire, to assess the sense of control over their child's epilepsy, and how much support they feel they received in various environments.
Methods: In this observational study, the data were collected using a questionnaire that was sent to families of children with epilepsy, who were treated at University Children's Hospital in Ljubljana, Slovenia from January to September 2016. The questionnaire consisted of 29 questions related to their epilepsy.